Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China.

Front Med (Lausanne) · 2025 · PMC12158739 · PMID 40510856

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

In this study, the numerical changes were not significant after initial or switch treatment (with a greater contribution from the switch group), but the difference was statistically significant, showing a favorable trend of change.

also in 887 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.